Study protocol: a multicentre, open-label, parallel-group, phase 2, randomised controlled trial of autologous macrophage therapy for liver cirrhosis (MATCH)

INTRODUCTION: Liver cirrhosis is a growing global healthcare challenge. Cirrhosis is characterised by severe liver fibrosis, organ dysfunction and complications related to portal hypertension. There are no licensed antifibrotic or proregenerative medicines and liver transplantation is a scarce resou...

Descripción completa

Detalles Bibliográficos
Autores principales: Brennan, Paul Noel, MacMillan, Mark, Manship, Thomas, Moroni, Francesca, Glover, Alison, Graham, Catriona, Semple, Scott, Morris, David M, Fraser, Alasdair R, Pass, Chloe, McGowan, Neil W A, Turner, Marc L, Lachlan, Neil, Dillon, John F, Campbell, John D M, Fallowfield, Jonathan Andrew, Forbes, Stuart J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Gastroenterology and Hepatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576470/
https://www.ncbi.nlm.nih.gov/pubmed/34750149
http://dx.doi.org/10.1136/bmjopen-2021-053190

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576470/
https://www.ncbi.nlm.nih.gov/pubmed/34750149
http://dx.doi.org/10.1136/bmjopen-2021-053190

Ejemplares similares